SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹111 Cr | ₹108 Cr | ₹103 Cr | ₹76 Cr | ₹68 Cr |
What is the latest Sundry Debtors ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹111 Cr |
| Mar2025 | ₹108 Cr |
| Mar2024 | ₹103 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹68 Cr |
How is Sundry Debtors of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹111 Cr | 2.75 | |
| Mar2025 | ₹108 Cr | 4.12 | |
| Mar2024 | ₹103 Cr | 36.81 | |
| Mar2023 | ₹76 Cr | 11.78 | |
| Mar2022 | ₹68 Cr | - | |
Compare Sundry Debtors of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,253.2 Cr | 19.5% | 19.4% | 48.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,280.0 Cr | -2.4% | -6.2% | 11.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,737.0 Cr | -3.3% | 1.4% | 57.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,129.0 Cr | -4.5% | -4% | 35.9% | Stock Analytics | |
| CIPLA | ₹108,808.0 Cr | -3.6% | -5% | -10.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,170.0 Cr | -0.2% | 2.5% | -3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 19.5% |
19.4% |
48.6% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses